Skip to Main Content

Paper Details

Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation.
Cell Rep
11
2021
/MLL1 target genes, H3K4, H3K4me, H3K4me3, MLL1, MLL1 complex, RBM, RBM39, RBM39 functional domains, RNA, RRM3, breast cancer, breast cancer cells, cancer, cancer cell, chromatin, normal cells
Author NameAffiliation
Alana L WelmUniversity of Utah
Alana L WelmUniversity of Utah
Chad D HuffMD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2